Home › Non-Small Cell Lung Cancer › Massachusetts › Newton
Non-Small Cell Lung Cancer clinical trials in Newton, MA
5 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Newton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Dana-Farber Cancer Institute at Boston Medical Center - Brighton, Brighton · 3 mi away
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecruitingPhase 1
- Dana-Farber Cancer Institute - Chestnut Hill, Newton
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RecruitingPhase 3
- Clinical Study Site, Brighton · 3 mi away
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RecruitingPhase 2/3
- Dana-Farber Cancer Institute at St. Elizabeths Medical Center, Brighton · 3 mi away
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Dana-Farber Cancer Institute - Chestnut Hill, Newton
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Newton
- Alzheimer's Disease12 studies
- Major Depressive Disorder10 studies
- Obesity9 studies
- Depression7 studies
- Overweight6 studies
- Psoriasis6 studies
- Chronic Pain4 studies
- Breast Cancer4 studies
- Schizophrenia4 studies
- Mild Cognitive Impairment4 studies
- Atopic Dermatitis (Eczema)4 studies
- Ulcerative Colitis4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.